Overview
Genexo has produced medical devices, prescription and over-the-counter medicines, and cosmetics for nearly 20 years. Its range includes glucose meters and accessories, an app and software for health monitoring, as well as inhalers, blood pressure monitors, thermometers, and scales for home use.
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 73 days for 2021). All were audited by a statutory auditor.
- 202518/06/2026
- 202414/07/2025
- 202316/07/2024
- 202212/07/2023
- 202126/09/2022
- 202011/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Public procurement
Genexo is the contractor in one public sector contract, worth USD 16.26.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 5, 2026 | Purchase of a blood glucose meter | $16.26 | Centrum Opiekuńczo-Mieszkalne w Grodzisku Mazowieckim |
Trademarks
Genexo holds 10 active trademarks registered with the Polish Patent Office. 1 application is pending. 25 marks have expired or were not registered. The first mark was filed in 1999.
| Mark | Protected until | |
|---|---|---|
| szkoła diabetyka | Jun 14, 2031 | |
| Wartix | Apr 4, 2029 | |
| ZDROWISIE(word) | Oct 12, 2027 | |
| PREL red - bezbolesny sposób na ból(word) | Dec 14, 2026 | |
| FOSANIC(word) | Oct 20, 2026 |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Storkan Limited | 6,725 | $90,829.28 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-08-23.
30 1240 6074 1787 0011 0317 3288- 39 1240 6074 1978 0011 0317 2597
- 48 1240 6074 1111 0011 0317 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $846,858.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 2, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $77,951$77,951 | Prezes Banku Gospodarstwa Krajowego | |
| Mar 20, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $19,920$19,920 | Certes sp. z o.o. | |
| Dec 5, 2022 | Liquidity support for undertakings affected by the war in Ukraine | $321.9K$321,866 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Farmak Internationalsp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Synoptis Pharmasp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Synoptis Industrialsp. z o.o. | $29,812,791.95 | synoptisindustrial.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| Xenico Pharmasp. z o.o. | $5,929,240.81 | xenico.pl |
Change history
| Date | Event | |
|---|---|---|
| 2014-02-03 | Share capital increase (306,000.00 PLN → 336,250.00 PLN) | |
| 2009-11-25 | Address change (Śmiała 51, 01-526, Warszawa → Gen.zajączka 26, 01-510, Warszawa) | |
| 2008-09-22 | Share capital increase (51,000.00 PLN → 306,000.00 PLN) | |
| 2003-05-08 | Share capital increase (50,000.00 PLN → 51,000.00 PLN) | |
| 2003-03-12 | Address change (Forteczna 1a, 01-540, Warszawa → Śmiała 51, 01-526, Warszawa) |
FAQ
Last updated: 2026-10-07